Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42, R43/R44)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages applications to NIA's Small Business Technology Transfer Research (STTR)program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.

Companion FOA: PAS-19-316, SBIR 43/44 - Phase I, Phase II, Direct-to-Phase II, and Fast Track


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • SBIR/STTR Deadlines: Sep. 5, Jan. 5, Apr. 5

PAS-19-317 Expiration Date September 07, 2022

Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

January 5, 2021